A new decision from the Brazilian Supreme Court on November 16th brought some hope to patent owners seeking the term adjustment for patents … New Decision From The Brazilian Supreme Court In Favor Of Patent Term Adjustment (PTA) Cases
A new decision from the Brazilian Supreme Court on November 16th brought some hope to patent owners seeking the term adjustment for patents … New decision from the Brazilian Supreme Court in favor of Patent Term Adjustment (PTA) cases
On November 8, 2022, the Brazilian Data Protection Authority (“Authority”) published its 2023-2024 Regulatory Agenda (“Current Agenda”), establishing high-priority topics over the … Brazilian Data Protection Authority publishes its 2023-2024 Regulatory Agenda
On October 19, 2022, the Brazilian House of Representatives approved Bill No. 2.796/2021 that creates a legal framework for the Brazilian gaming … Bill creates Legal Framework for the Electronic Games Industry in Brazil
The Federal Council of Medicine (CFM) published, on 10/14/2022, CFM Resolution No. 2,324/22, which authorizes the use of cannabidiol (CBD) for treatment … CFM updates its Resolution on cannabidiol prescription and use
While registration is not mandatory in Brazil for copyright protection, it is a recommended measure as it may serve as evidence of … Copyright registration in Brazil may now be submitted via online system
ANVISA published, in the Federal Official Gazette, RDC No. 751/2022, which provides and defines, in relation to medical devices, the (i) risk classification rules; (ii) labeling … ANVISA approves new Resolution RDC related to Medical Devices
The new generations of products are the result of the increasing combination of different technologies, leading to a crossing of borders between … Combined products in Brazil – brief comments on Anvisa’s (Brazilian National Health Surveillance Agency) current understanding
The Ministry of Health (MH) sent Brazilian National Health Surveillance Agency (Anvisa) a request for exemption from the sanitary registration, on an … Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health
On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological … Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim
